BioHealth News Archive
Novartis buys remaining rights to GSK treatment in deal up to $1B
Novartis has agreed to buy all remaining rights to Ofatumumab from Britain's GlaxoSmithKline for up to $1 billion, boosting the Swiss drugmaker's stable of…
Read MoreRegister Today for the NIH SBIR/STTR Conference!
October 27 – 29, 2015 (Seattle, WA) The 17th Annual NIH SBIR/STTR Conference will be held in Seattle, Washington on October 27 – 29,…
Read MoreWIB-DC/Baltimore Announces Its 1:1 Mentoring Program
The WIB-DC/Baltimore Mentors, Advisors, and Peers (MAPs) Committee is thrilled to announce the initiation of our 1:1 Mentoring Program. This program is designed to…
Read MoreGaithersburg startup ExeGi’s probiotic studied for effect on HIV patients – Washington Business Journal
Most consumers are familiar with the idea of probiotics — particularly when it comes to gastrointestinal health. But could they actually benefit HIV and…
Read MoreThe Maryland Open Bloody-Mary and Crab-Soup Competitions
Startup Maryland and LAUNCH! Annapolis today announced a teaming relationship under which both organizations present the 2015 Maryland Open Bloody-Mary and Crab-Soup Competitions. Contested…
Read MoreBrainScope Lands Addtional $500K from GE and names Executive Appointments
BrainScope Company, Inc., a privately held neurotechnology company with an initial focus on traumatic brain injury (TBI) and concussion assessment, is feeling a lot…
Read MoreUnited Therapeutics to sell for rare pediatric disease treatments to AbbVie for $350 million – Washington Business Journal
United Therapeutics (Nasdaq: UTHR) is selling a voucher designed to speed up approval for rare pediatric disease treatments to Chicago-based pharmaceutical company AbbVie Inc.…
Read MoreSara Nayeem Panelist at Biotechnology Industry Organization Webinar – NEA
Sara Nayeem will participate in the Biotechnology Industry Organization webinar entitled, "Capturing Investor Interest in a Hot Biotech Climate," on Tuesday, August 18th at…
Read MoreGoogle’s conversion to Alphabet highlights far-flung operations in biotech, venture capital funding – IPWatchdog.com | Patents & Patent Law
Google Inc. (NASDAQ:GOOG) is a major consumer technology developer and Internet services giant which is involved in an incredibly diverse array of innovative tech…
Read MoreRelevant Health Application Deadline is this Friday, August 21st
Applications for consideration in Relevant Health's first cohort must be submitted by this Friday, August 21st at 11:59pm Eastern Time. Complete or submit your…
Read MoreAt Synthorx, Synthetic Biologists Put Artificial Life Forms to Work | MIT Technology Review
In the May 15, 2014, edition of the journal Nature, Floyd Romesberg’s chemistry lab at San Diego’s Scripps Research Institute published a paper titled…
Read MoreBio by-product: Why Emergent BioSolutions spun out a new company – Washington Business Journal
The company is just so much better known its medical countermeasures against biological threats like anthrax than for its cancer work, and that's a…
Read MoreGlucoTrack Non-Invasive Ear Lobe Glucometer to Go to Clinical Trial in U.S. | Medgadget
We’ve been covering news of the GlucoTrack non-invasive glucometer for almost a decade now, and finally Integrity Applications, the company behind the device, is moving…
Read MoreTransgenic Pigs Shatter Transplant Records – MIT Technology Review
With the financial aid of a biotechnology executive whose daughter may need a lung transplant, U.S. researchers have been shattering records in xenotransplantation, or…
Read MoreBetamore, Plank Industries to host Beta City startup showcase – Baltimore Business Journal
Betamore and Plank Industries, Under Armour CEO Kevin Plank’s private investment arm, are teaming up to showcase Baltimore startups in a new entrepreneurship event.…
Read More